Next report date
Report period
H2 2024
EPS estimate
—
Revenue estimate
8.53 MEUR
2.0EUR
9.74 MEUR
14.91 MEUR
4.29 M
About BIOVENTIX PLC LS -,05
Sector
CEO
Peter J. Harrison
Website
Headquarters
Farnham
Founded
2003
ISIN
GB00B4QVDF07
FIGI
BBG00HY3PWZ2
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIOVENTIX PLC LS -,05 stocks are traded under the ticker 51B.
BIOVENTIX PLC LS -,05 is going to release the next earnings report on Oct 28, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track BIOVENTIX PLC LS -,05 financials in yearly and quarterly reports right on TradingView.
51B net income for the last quarter is 4.64 M EUR, while the quarter before that showed 5.40 M EUR of net income which accounts for −14.09% change. Track more BIOVENTIX PLC LS -,05 financial stats to get the full picture.
BIOVENTIX PLC LS -,05 dividend yield was 3.95% in 2023, and payout ratio reached 94.63%. The year before the numbers were 4.41% and 103.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 51B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOVENTIX PLC LS -,05 stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on BIOVENTIX PLC LS -,05 future price: according to them, 51B price has a max estimate of 68.80 EUR and a min estimate of 68.80 EUR. Read a more detailed BIOVENTIX PLC LS -,05 forecast: see what analysts think of BIOVENTIX PLC LS -,05 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOVENTIX PLC LS -,05 EBITDA is 12.51 M EUR, and current EBITDA margin is 79.38%. See more stats in BIOVENTIX PLC LS -,05 financial statements.